Cancer Genetics (CGIX) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Cancer Genetics Announces Strong Second Quarter 2015 Results
August 11, 2015 7:30 AM EDTSecond Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award of Largest Clinical Trial in Company's History Further Validation of CGI's Bench to Bedside Strategy Secured strategic alliance with ICON plc, a global CRO for the biopharma community Announced that it has entered into an agreement to acquire assets and operations of Response Genetics, Inc. (OTCQB: RGDX)
RUTHERFORD, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in... More
Cancer Genetics Announces Strong Second Quarter 2015 Results
August 11, 2015 7:30 AM EDTSecond Quarter Revenues up 177 Percent Year-over-Year; Six-Months Ended June 30, 2015 Revenues up 191 Percent Year-over-Year Recent Award of Largest Clinical Trial in Company's History Further Validation of CGI's Bench to Bedside Strategy Secured strategic alliance with ICON plc, a global CRO for the biopharma community Announced that it has entered into an agreement to acquire assets and operations of Response Genetics, Inc. (OTCQB: RGDX)
RUTHERFORD, N.J., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), an emerging leader in... More
